APA (7th ed.) Citation

Minckwitz, G. v., Conrad, B., Reimer, T., Decker, T., Eidtmann, H., Eiermann, W., . . . Loibl, S. (2015). A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52). Cancer, 121(20), .

Chicago Style (17th ed.) Citation

Minckwitz, Gunter von, et al. "A Randomized Phase 2 Study Comparing EC or CMF Versus Nab-paclitaxel Plus Capecitabine as Adjuvant Chemotherapy for Nonfrail Elderly Patients with Moderate to High-risk Early Breast Cancer (ICE II-GBG 52)." Cancer 121, no. 20 (2015).

MLA (9th ed.) Citation

Minckwitz, Gunter von, et al. "A Randomized Phase 2 Study Comparing EC or CMF Versus Nab-paclitaxel Plus Capecitabine as Adjuvant Chemotherapy for Nonfrail Elderly Patients with Moderate to High-risk Early Breast Cancer (ICE II-GBG 52)." Cancer, vol. 121, no. 20, 2015.